Trial Profile
Retrospektive Studie zu Patientinnen, Die pranatal, Perinatal Oder Postnatal Prophylaktisch Oder Therapeutisch Mit Fondaparinux Behandelt Wurden.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Sep 2023
Price :
$35
*
At a glance
- Drugs Fondaparinux sodium (Primary)
- Indications Thromboembolism
- Focus Adverse reactions
- Acronyms FondaPPP
- Sponsors GlaxoSmithKline; GSK
- 05 Nov 2010 Actual end date (1 Jul 2010) added as reported by ClinicalTrials.gov record.
- 05 Nov 2010 Actual initiation date changed from 1 Feb 2010 to 1 May 2010 as reported by ClinicalTrials.gov record.
- 05 Nov 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.